The 20 Best Maturity Onset Diabetes of the Young Doctors Near Me in Pasadena, MD

Kristin Flammer is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Flammer is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Nodule, Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

Justin Tcheugui is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Tcheugui is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Gestational Diabetes, and Type 1 Diabetes (T1D). Dr. Tcheugui is board certified in American Board Of Internal Medicine.

Kathleen Prendergast is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Prendergast is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Neuropathy, Maturity Onset Diabetes of the Young, and Hypothyroidism.

Christopher Ish, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Glen Burnie. He also serves as office medical director at the practice. Dr. Ish received his medical degree from the University of Medicine and Dentistry of New Jersey and completed his residency training in internal medicine and pediatrics at University of Maryland Medical Center in Baltimore. He is an instructor of medicine at The Johns Hopkins University School of Medicine in Baltimore. Dr. Ish is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sitosterolemia, and Scleroderma. Dr. Ish is board certified in American Board Of Internal Medicine and American Board Of Pediatrics.

Patrick Dantzer, M.D., practices pediatrics at Johns Hopkins Community Physicians Glen Burnie. He received his medical degree from Wayne State University School of Medicine, and also completed his residency in internal medicine & pediatrics at Children's Hospital of Pittsburgh. Dr. Dantzer is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. His clinical expertise encompasses Premenstrual Dysphoric Disorder, Acute Cerebellar Ataxia, Maturity Onset Diabetes of the Young, and Type 2 Diabetes (T2D). Dr. Dantzer is board certified in American Board Of Internal Medicine and American Board Of Pediatrics.

Ritha Chea, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Glen Burnie. She received her medical degree from Wayne State University School of Medicine in Detroit. She completed her residency in internal medicine and pediatrics at University of Maryland Medical Center in Baltimore. Dr. Chea is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. Her clinical expertise encompasses Type 2 Diabetes (T2D), Sitosterolemia, Osteomyelitis in Children, and High Cholesterol. Dr. Chea is board certified in American Board Of Internal Medicine and American Board Of Pediatrics.

Ricardo Osorno is a primary care provider, practicing in Internal Medicine in Pasadena, Maryland. Dr. Osorno is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. His clinical expertise encompasses Type 2 Diabetes (T2D), Hypertension, Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Osorno is currently accepting new patients.

Tatyana Sergeyeva is an Endocrinologist practicing medicine in Glen Burnie, Maryland. Dr. Sergeyeva is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Hypothyroidism, Toxic Nodular Goiter, and Obesity in Children.

David Schwartz is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Schwartz is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Type 2 Diabetes (T2D), Hemochromatosis, and Hypertensive Heart Disease. Dr. Schwartz is currently accepting new patients.

Peter Ramirez is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Ramirez is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and Endoscopy. Dr. Ramirez is currently accepting new patients.

Michael Downing is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Downing is rated as an Experienced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. His clinical expertise encompasses Migraine with Brainstem Aura, Familial Hemiplegic Migraine, High Cholesterol, and Attention Deficit Hyperactivity Disorder (ADHD). Dr. Downing is currently accepting new patients.

Sherita Golden is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Golden is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Hormone Replacement Therapy (HRT).

Dr. Sudipa Sarkar is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include endocrinology. She received her M.D. from Yale School of Medicine. She completed her residency in internal medicine at Yale-New Haven Hospital and performed a fellowship in endocrinology, diabetes and metabolism at Vanderbilt University Medical Center. Dr. Sarkar joined the Johns Hopkins faculty in 2017. Dr. Sarkar is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Type 2 Diabetes (T2D), Diabetic Retinopathy, Maturity Onset Diabetes of the Young, Diabetic Neuropathy, and Sleeve Gastrectomy. Dr. Sarkar is board certified in American Board Of Internal Medicine.

Dr. Prasanna Santhanam received his M.B.B.S. from B.J. Medical College and his M.D. from N.H.L. Municipal Medical College. He completed a residency in internal medicine, Joan C Edwards School of Medicine, Marshall University and a fellowship in endocrinology, diabetes, and metabolism at Joan C Edwards School of Medicine, Marshall University. He underwent additional training in nuclear medicine, at the Department of Radiology and Radiological Sciences at Johns Hopkins University School of Medicine, to pursue his research and clinical interests in nuclear medicine and molecular imaging of endocrine glands and disorders. His clinical interests include thyroid disorders, endocrine neoplasms, and research focus on metabolic and molecular imaging of endocrine tissues and predictive analytics in metabolic disorders. Dr. Santhanam is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Follicular Thyroid Cancer, Papillary Thyroid Cancer, Anaplastic Thyroid Cancer, and Thyroidectomy.

Dr. Rita Kalyani is a Professor of Medicine at Johns Hopkins School of Medicine. She graduated with an undergraduate degree from Harvard College and completed her medical degree, residency, and fellowship at Johns Hopkins. She also obtained a Masters in Health Science degree in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. As a NIH-funded clinician scientist, Dr. Kalyani has authored over 175 peer-reviewed publications and built a research program focused on understanding the factors leading to development of diabetes complications, particularly in high-risk populations. She has conducted epidemiological and patient-oriented research that has led to fundamental discoveries regarding the development of skeletal muscle loss, physical disability, and frailty in diabetes. She has also spearheaded studies investigating sex differences in cardiovascular disease and diabetes which have influenced primary prevention guidelines. Dr. Kalyani launched the Diabetes Management Service for Johns Hopkins’ Total Pancreatectomy Islet Auto Transplant Program in 2011. She is the co-founder of the Johns Hopkins Diabetes POC-IT Guide for healthcare professionals. She is also the founder and past Editor-in-Chief of the Johns Hopkins Patient Website to Diabetes. Dr. Kalyani has been the Chief Scientific and Medical Officer of the American Diabetes Association since 2025. She previously served as President of Medicine & Science on the ADA's National Board of Directors. She continues to have a clinical practice as an adult endocrinologist. Dr. Kalyani is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Seasonal Affective Disorder (SAD), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Pancreatectomy, and Islet Cell Transplantation.

Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously. Dr. Donner is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 1 Diabetes (T1D), Diabetic Nephropathy, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. Dr. Donner is board certified in American Board Of Internal Medicine.

Todd T. Brown, MD, PhD is a clinical investigator who focuses on body composition, metabolic, and skeletal abnormalities observed in people with HIV, particularly as related to aging. Through translational investigation, epidemiologic studies, and clinical trials, he has been interested in understanding the pathogenesis of glucose disorders, fat changes, hormonal dysregulation, and osteoporosis in people with HIV, the consequences of these conditions (eg cardiovascular disease, frailty), and their optimal evaluation and management. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Low Blood Sugar, Osteoporosis, Malnutrition, Gastric Bypass, and Gastrostomy.

Dr. Mathioudakis, an endocrinologist and researcher, has a strong focus on diabetes management and patient care, recognized through awards like the Baltimore Top Doc. He has contributed significantly to diabetes research, authoring over 150 publications and participating in the development of consensus guidelines in the field. His studies have offered valuable insights into using health informatics for diabetes prevention and management. After graduating from the Johns Hopkins University School of Medicine and completing his training in Internal Medicine and a fellowship in Endocrinology, Diabetes, & Metabolism, Dr. Mathioudakis joined the faculty in the Division of Endocrinology, Diabetes & Metabolism in 2012. He earned a Master of Health Science in clinical investigation in 2015 and was the Clinical Director of the Division of Endocrinology from 2016 to 2021. Currently, he co-directs the Baltimore Metropolitan Diabetes Regional Partnership, focusing on improving access to diabetes prevention and management programs. As a physician-scientist, Dr. Mathioudakis leads multiple research studies funded by the NIH, private philanthropic organizations (Helmsley Charitable Trust), non-profit organizations (Breakthrough T1D), and industry. His research focuses on the effectiveness of automated diabetes prevention programs and strategies to reduce racial disparities in diabetes technology access. He also collaborates nationally to enhance care for people with type 1 diabetes. Holding a joint appointment in the Division of Biomedical Informatics and Data Science, Dr. Mathioudakis integrates machine learning and AI in diabetes research. He has served on the national Epic Endocrinology Specialty Steering Board and chaired the Type 2 Diabetes Prognostics Working Group for the Precision Medicine Diabetes Initiative. Committed to education, he frequently lectures on endocrinology, epidemiology, and health informatics. Dr. Mathioudakis is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Type 1 Diabetes (T1D), Low Blood Sugar, Diabetic Ketoacidosis, and Pancreaticoduodenectomy.

Sheela N. Magge, M.D., M.S.C.E., is a pediatric endocrinologist and the director of the Division of Pediatric Endocrinology, as well as the Lawson Wilkins Endowed Chair of Pediatric Endocrinology at Johns Hopkins Children’s Center. Dr. Magge’s expertise includes the diagnosis and treatment of endocrine disorders in children and adolescents. Primary related conditions that she treats include type 2 diabetes mellitus, pre-diabetes, obesity, congenital insulin resistance syndromes, congenital lipodystrophy and polycystic ovary syndrome. Dr. Magge is an active member of the National Pediatric Endocrine Society. She is also a standing member of the National Institutes of Health (NIH) Human Studies of Diabetes and Obesity Study Section. A professor of pediatrics, Dr. Magge obtained a master’s degree in clinical epidemiology from the University of Pennsylvania. Dr. Magge is rated as an Advanced provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Obesity, Type 2 Diabetes (T2D), Congenital Hyperinsulinism, and Maturity Onset Diabetes of the Young. Dr. Magge is board certified in American Board Of Pediatrics.

Kashif Munir is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Munir is rated as a Distinguished provider by MediFind in the treatment of Maturity Onset Diabetes of the Young. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Thyroid Cancer, Thyroid Storm, Pituitary Tumor, and Thyroidectomy.